Prognosis of Cerebral Small Vessel Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognosis of Cerebral Small Vessel Disease — Stella

Home/Cerebral Amyloid Angiopathy/

View on ClinicalTrials.gov

Recruiting

Back to Cerebral Amyloid Angiopathy trials

Trial locations(1 site)

Switzerland

Department of Neurology, Inselspital Bern University Hospital, Bern

Key details

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment target

~900 participants

Started

December 2020

Primary completion

November 2030

Age range

16 Years and older

Last updated March 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.